First, what is rosacea?

Rosacea is a chronic inflammatory skin condition most commonly affecting the central face.

It can present with persistent redness, episodic flushing, visible small blood vessels, inflammatory papules or pustules, burning, stinging and heightened skin sensitivity.

The biology is complex. Rosacea involves an interaction between the skin's innate immune system, vascular reactivity, neurovascular signalling, barrier dysfunction and environmental triggers.

This helps explain why rosacea-prone skin may respond differently to heat, UV exposure, skincare products and physical procedures.

What is Profhilo?

Profhilo is an injectable treatment containing stabilised hyaluronic acid.

Unlike a conventional dermal filler, it is not primarily used to create projection or replace volume in a specific facial structure. It is injected at selected points and distributes within the tissue.

Hyaluronic acid itself is naturally present in human skin and forms an important part of the extracellular matrix.

However, describing hyaluronic acid simply as a substance that “hydrates the skin” overlooks much of its biology.

Why might injectable hyaluronic acid aggravate rosacea?

There are several overlapping biological processes that make a relationship plausible.

1. The injection itself creates tissue injury

Every injection passes through the epidermis and dermis and creates a small degree of controlled tissue trauma.

This can produce transient inflammation, vascular dilation, redness and swelling even in someone without rosacea.

In rosacea-prone skin, where vascular and inflammatory responses may already be exaggerated, that disturbance may be enough to contribute to a flare.

2. Hyaluronic acid is biologically active

Hyaluronic acid is not simply an inert gel sitting within the skin. It participates in cell signalling and tissue homeostasis.

Importantly, its biological effects can differ according to molecular weight and the surrounding tissue environment.

Higher-molecular-weight hyaluronic acid is generally associated with tissue homeostasis and anti-inflammatory effects, whereas smaller HA fragments generated during tissue injury and degradation can participate in pro-inflammatory signalling.

3. Tissue injury can alter HA signalling

Inflammation and oxidative stress influence the extracellular matrix and the metabolism of hyaluronic acid.

Fragments of HA produced in an injured or inflamed environment can act as signalling molecules and interact with components of the innate immune system.

4. That matters particularly in rosacea

Abnormal innate immune signalling forms part of current understanding of rosacea biology. Toll-like receptor pathways, particularly TLR2, have been implicated in the exaggerated inflammatory response seen in rosacea.

This creates a plausible biological connection between local tissue injury, HA metabolism, inflammatory signalling and a flare in skin already predisposed to rosacea.

But hyaluronic acid is not simply pro-inflammatory

This is an important part of the story.

The biological effect of hyaluronic acid varies considerably with its molecular size, formulation and tissue context. Some forms of HA are associated with anti-inflammatory and tissue-repair effects.

There is even experimental and emerging clinical interest in certain forms of hyaluronic acid as potential modulators of inflammation in rosacea.

So the relationship should not be simplified to: “hyaluronic acid causes inflammation.” That would be inaccurate.

A better model is that the response depends on the HA formulation, local degradation, injection trauma, oxidative environment, the state of the skin at the time of treatment and the individual's underlying susceptibility.

Normal post-injection redness or a rosacea flare?

Redness immediately after injections is common and does not automatically mean rosacea has been aggravated.

There is no perfect visual test that separates the two, and an unusual or persistent reaction after an injectable treatment should be clinically assessed rather than self-diagnosed.

Can Profhilo actually cause rosacea?

There is currently insufficient evidence to say that Profhilo causes rosacea in someone who would otherwise never have developed the condition.

A more plausible possibility is that treatment may expose or aggravate an underlying tendency that was already present.

Someone may, for example, have a history of intermittent flushing or skin sensitivity without ever having received a formal diagnosis. An inflammatory trigger can make that tendency considerably more obvious.

Should you have Profhilo during an active rosacea flare?

As a general principle, we would be cautious about elective injectable treatment through actively inflamed or significantly reactive skin.

If the face is currently very red, burning, inflamed or experiencing an obvious rosacea flare, it may be more appropriate to stabilise the skin first and reconsider injectable treatment afterwards.

Can you have Profhilo if your rosacea is well controlled?

Potentially, yes.

A history of rosacea is not automatically a contraindication to injectable hyaluronic acid treatment. The decision should be individualised.

What if your rosacea flares after Profhilo?

Do not assume that all redness is simply a normal reaction to injections, particularly if it is worsening rather than settling.

Contact the treating clinic if redness is unusually persistent, spreading, increasingly uncomfortable or accompanied by a change in the character of your usual rosacea.

The first priority is to establish what is happening. Persistent redness after injections has several possible explanations and should not automatically be labelled as rosacea.

Our approach: treat the skin you have today

One of the problems with aesthetic treatment plans is the assumption that a procedure which is normally well tolerated must therefore be appropriate on every occasion.

Skin changes. Rosacea changes. Barrier function changes. Inflammatory activity changes.

Someone who tolerated an injectable treatment perfectly six months ago may present with substantially more reactive skin today.

For patients with rosacea, we therefore think the condition of the skin at the time of treatment matters just as much as the name of the procedure being booked.

Profhilo & Rosacea FAQs

So, is there a link?

There is a plausible biological link between the local response to injectable hyaluronic acid treatment and a rosacea flare in susceptible skin.

The relationship is likely to be more complex than the injected HA itself. Needle trauma, local inflammation, oxidative stress, HA metabolism, vascular reactivity, innate immune signalling and the patient's underlying rosacea susceptibility may all contribute.

What we cannot currently say is that Profhilo has been demonstrated to cause rosacea, or that every episode of redness following treatment represents a rosacea flare.

For us, that uncertainty is a reason for better patient selection and observation — not a reason to ignore a clinically plausible association.